SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Axon Enterprise, Inc. (AXON), formerly Taser Intl. -- Ignore unavailable to you. Want to Upgrade?


To: im a survivor who wrote (558)2/13/2005 10:27:45 AM
From: John Carragher  Read Replies (1) | Respond to of 974
 
insider sales,, no problems sec was investigating the sale to the distributor of about $1million to inflate books. This was explained sufficiently to me during conference call. Law suits are junk law suits. we need more tort reform and less lawyers,, sent them to college to major in science or teaching.

all the law suits will be combined into one suit for court hearing and then thrown out.

stock is down because of bad press, and question about safety not because of insider sales.

bottom line, tasr does not have a safety problem, it has a pr problem fighting the shorts who are out to bring stock down. They have a problem with every ambulance chaser who sees money at the end if they can just win one suit.

My investment is not large. it is speculation. see ya



To: im a survivor who wrote (558)2/13/2005 1:50:38 PM
From: Jill  Read Replies (1) | Respond to of 974
 
I agree. But the 14 year old boy dying is a huge concern. It's one thing if an elderly person with heart trouble dies. Its another if a healthy young boy dies. Then the weapons have to be reclassified.